Physician profile
Thomas Dust
NPI 1477984656
$3,717.05
in general payments reported to CMS, 2019-2025
42 companies · $2,001 in 2025
The $2,001 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,060 · 2022: $431 · 2023: $151 · 2024: $74.41 · 2025: $2,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731 · Education: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.56 |
| Education | $496.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $379.87 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Novo Nordisk INC | $362.53 | 2021-2023 | Ozempic |
| Janssen Biotech, INC. | $324.28 | 2023-2025 | Rybrevant, Darzalex, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $247.05 | 2021-2025 | Enhertu, Lynparza, Imfinzi |
| Abbvie INC. | $236.72 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $224.93 | 2025 | |
| Merck Sharp & Dohme LLC | $202.22 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Seagen INC. | $198.00 | 2025 | |
| Pfizer INC. | $147.55 | 2021-2025 | |
| Eisai INC. | $130.68 | 2021-2025 | |
| Daiichi Sankyo INC. | $110.52 | 2021-2025 | Enhertu, Injectafer |
| Janssen Pharmaceuticals, INC | $108.39 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $78.78 | 2025 | Libtayo |
| Biohaven Pharmaceutical Holding Company LTD. | $76.68 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.53 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.